<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="900">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04592055</url>
  </required_header>
  <id_info>
    <org_study_id>UU-DM002</org_study_id>
    <nct_id>NCT04592055</nct_id>
  </id_info>
  <brief_title>The Effect of COVID-19 on Diabetes Mellitus</brief_title>
  <acronym>COVID-19-DM</acronym>
  <official_title>The Effect of COVID-19 on the Glycemic Control in Patients With Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Uşak University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Uşak University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aimed to evaluate the effect of SARS-COV-2 infection on metabolic status in&#xD;
      patients with diabetes mellitus. Patients' HbA1c levels before and after SARS-COV-2 infection&#xD;
      will be evaluated.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this time pediods, all patients with RT-PCR positive for SARS-COV-2 will be analysed for&#xD;
      the presence of diabetes mellitus. Previous HbA1c levels will be obtained from hospital&#xD;
      records. In these patients, previous A1c levels and A1c levels 3 months after the SARS-COV-2&#xD;
      infection will be compared.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 20, 2020</start_date>
  <completion_date type="Anticipated">November 1, 2020</completion_date>
  <primary_completion_date type="Actual">October 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>A1c</measure>
    <time_frame>6 months (3 months before and after COVID-19</time_frame>
    <description>the change in A1c levels</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Diabetes Mellitus</condition>
  <condition>Covid19</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All hospitalised diabetic patients with RT-PCR- positive for SARS-COV-2 will be enrolled&#xD;
        and evaluated.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - All hospitalised diabetic patients with RT-PCR- positive for SARS-COV-2 will be enrolled.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - The absence of diabetes mellitus RT-PCR- negative for SARS-COV-2 Non-hospitalised&#xD;
        patients&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Cevdet Duran, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Uşak University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cevdet Duran</last_name>
    <phone>02762212121</phone>
    <email>drcduran@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Usak University Training and Research Hospital</name>
      <address>
        <city>Usak</city>
        <zip>64200</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cevdet Duran</last_name>
      <phone>05334298585</phone>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 16, 2020</study_first_submitted>
  <study_first_submitted_qc>October 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2020</study_first_posted>
  <last_update_submitted>October 16, 2020</last_update_submitted>
  <last_update_submitted_qc>October 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

